Literature DB >> 3734881

Results of surgical treatment of neurocysticercosis in 69 cases.

B O Colli, N Martelli, J A Assirati, H R Machado, S de Vergueiro Forjaz.   

Abstract

The clinical course of 69 patients with neurocysticercosis who underwent surgery to control increased intracranial pressure (ICP) or cyst removal is analyzed. Increased ICP was caused by hydrocephalus in 63 patients, by cerebral edema in four, and by giant cysts in two. Skull x-ray films showed calcifications in 14% and signs of elevated ICP in 46%. Examination of cerebrospinal fluid (CSF) revealed pleocytosis with eosinophils in 52% of cases and a positive complement fixation test for cysticercosis in 66%. Ventriculography allowed localization of the CSF obstruction and ventricular cysts, and generally differentiated between an obstruction due to cysts and an inflammatory process. Computerized tomography showed cysts in the cerebral parenchyma and ventricular dilatation. Ventricular cysts were best seen when intraventricular metrizamide was used. Intracranial shunting and posterior fossa exploration were less effective in the treatment of hydrocephalus than was ventriculoatrial (VA) or ventriculoperitoneal (VP) shunting, although VA or VP shunting was associated with a high percentage of complications. Quality of survival was good in 87% of the cases in the first 3 postoperative months and in 93% of patients who survived 2 years after surgery. Forty-seven patients (68%) were readmitted one or more times for CSF shunt revision; 14 of them for shunt infection (meningitis). The early operative mortality rate was 1.8% for patients with VA or VP shunt placement and 5.3% for those with posterior fossa exploration. The authors conclude that placement of CSF shunts is indicated in the treatment of hydrocephalus, and cyst removal is indicated only when the cyst exhibits tumor-like behavior. Surgical exploration is also indicated when the diagnosis is uncertain.

Entities:  

Mesh:

Year:  1986        PMID: 3734881     DOI: 10.3171/jns.1986.65.3.0309

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  25 in total

1.  Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel.

Authors:  D A Allcut; A Coulthard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

2.  Emergency neuroendoscopic management of third ventricular neurocysticercosis cyst presented with bruns syndrome : report of two cases and review of literature.

Authors:  Ramesh Teegala; K Ghanta Rajesh; V Yerramsetty Raviprasad; Yemba Chennappa
Journal:  J Korean Neurosurg Soc       Date:  2014-03-31

3.  Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery.

Authors:  Jefferson V Proaño; Jaime Torres-Corzo; Roberto Rodríguez-Della Vecchia; Gabriel Guizar-Sahagun; Leonardo Rangel-Castilla
Journal:  Childs Nerv Syst       Date:  2009-06-26       Impact factor: 1.475

4.  Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy.

Authors:  J Fandiño; C Botana; C Fandiño; D Rodriguez; J Gomez-Bueno
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Neurocysticercosis--a review of 231 cases.

Authors:  L Monteiro; T Coelho; A Stocker
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

6.  Parasitosis and mycosis of the central nervous system: 20 years of experience.

Authors:  A Krivoy; E Casale; R D Valdivia; V Silva; A Gonzalez
Journal:  Childs Nerv Syst       Date:  1988-04       Impact factor: 1.475

7.  Endoscopic excision of intraventricular neurocysticercosis in children: a series of six cases and review.

Authors:  Ashish Suri; Rohit Kumar Goel; Faiz Uddin Ahmad; Ananth Kesav Vellimana; Bhawani Shankar Sharma; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2007-11-10       Impact factor: 1.475

8.  MRI in intraventricular neurocysticercosis: a case report.

Authors:  K A Hanlon; B A Vern; W S Tan; E Passen; J J Jafar
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

Review 9.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.